Symmetric bis-benzimidazoles as DNA minor groove-binding agents with anti-tumour and antibacterial activity, and the evolution of the drug ridinilazole for the treatment of Clostridium difficile infections.
Bioorg Med Chem
; 58: 116656, 2022 03 15.
Article
in En
| MEDLINE
| ID: mdl-35183028
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridines
/
Benzimidazoles
/
DNA
/
Clostridium Infections
/
Anti-Bacterial Agents
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Bioorg Med Chem
Journal subject:
BIOQUIMICA
/
QUIMICA
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: